OS Therapies (OSTX)
Develops Listeria immunotherapy for recurrent metastatic osteosarcoma after surgery.
$1.75
Pre-market+0.04 (+2.04%)
At close$1.72(+3.31%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$0.15
Revenue estimate
$1.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.18−$0.19−$0.21−$0.35−$0.27−$0.20−$0.20Pending
Estimate−$0.11−$0.15−$0.16−$0.14−$0.17−$0.18−$0.18−$0.15
Surprise−63.6%−26.7%−31.2%−157.4%−58.8%−12.4%−12.4%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate————$971.0K$750.0K$750.0K$1.0M
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.18 | −$0.20 | −12.4% |
| Aug 2026 | −$0.18 | −$0.20 | −12.4% |
| May 2026 | −$0.17 | −$0.27 | −58.8% |
| Mar 2026 | −$0.14 | −$0.35 | −157.4% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.15 | — | — | $1.0M | — | — | — |
| Aug 17, 2026 | −$0.18 | −$0.20 | −12.4% | $750.0K | — | — | −9.3% |
| Aug 14, 2026 | −$0.18 | −$0.20 | −12.4% | $750.0K | — | — | +1.3% |
| May 18, 2026 | −$0.17 | −$0.27 | −58.8% | $971.0K | — | — | +1.7% |
| Mar 31, 2026 | −$0.14 | −$0.35 | −157.4% | — | — | — | −3.6% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 19, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 15, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 20, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||